These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3816420)

  • 21. Proteoglycans in haemopoietic cells.
    Kolset SO; Gallagher JT
    Biochim Biophys Acta; 1990 Dec; 1032(2-3):191-211. PubMed ID: 2261494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin is essential for the storage of specific granule proteases in mast cells.
    Humphries DE; Wong GW; Friend DS; Gurish MF; Qiu WT; Huang C; Sharpe AH; Stevens RL
    Nature; 1999 Aug; 400(6746):769-72. PubMed ID: 10466726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure and function of the family of proteoglycans that reside in the secretory granules of natural killer cells and other effector cells of the immune response.
    Stevens RL; Kamada MM; Serafin WE
    Curr Top Microbiol Immunol; 1989; 140():93-108. PubMed ID: 2644078
    [No Abstract]   [Full Text] [Related]  

  • 24. Homology of the rat basophilic leukemia cell and the rat mucosal mast cell.
    Seldin DC; Adelman S; Austen KF; Stevens RL; Hein A; Caulfield JP; Woodbury RG
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3871-5. PubMed ID: 3923482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mast cell proteoglycans.
    Rönnberg E; Melo FR; Pejler G
    J Histochem Cytochem; 2012 Dec; 60(12):950-62. PubMed ID: 22899859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carboxypeptidase A in mouse mast cells. Identification, characterization, and use as a differentiation marker.
    Serafin WE; Dayton ET; Gravallese PM; Austen KF; Stevens RL
    J Immunol; 1987 Dec; 139(11):3771-6. PubMed ID: 3680950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypic changes of bone marrow-derived mast cells after intraperitoneal transfer into W/Wv mice that are genetically deficient in mast cells.
    Otsu K; Nakano T; Kanakura Y; Asai H; Katz HR; Austen KF; Stevens RL; Galli SJ; Kitamura Y
    J Exp Med; 1987 Mar; 165(3):615-27. PubMed ID: 3102674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of carboxypeptidase and tryptic esterase activities that are complexed to proteoglycans in the secretory granules of human cloned natural killer cells.
    Kamada MM; Michon J; Ritz J; Holldack J; Serafin WE; Austen KF; MacDermott RP; Stevens RL
    J Immunol; 1989 Jan; 142(2):609-15. PubMed ID: 2911013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serglycin determines secretory granule repertoire and regulates natural killer cell and cytotoxic T lymphocyte cytotoxicity.
    Sutton VR; Brennan AJ; Ellis S; Danne J; Thia K; Jenkins MR; Voskoboinik I; Pejler G; Johnstone RW; Andrews DM; Trapani JA
    FEBS J; 2016 Mar; 283(5):947-61. PubMed ID: 26756195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin proteoglycans released from rat serosal mast cells inhibit proliferation of rat aortic smooth muscle cells in culture.
    Wang Y; Kovanen PT
    Circ Res; 1999 Jan 8-22; 84(1):74-83. PubMed ID: 9915776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, beta-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells.
    Razin E; Mencia-Huerta JM; Stevens RL; Lewis RA; Liu FT; Corey E; Austen KF
    J Exp Med; 1983 Jan; 157(1):189-201. PubMed ID: 6184439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of secretory granule proteases in mouse mast cells exposed to interleukin 3 and c-kit ligand.
    Gurish MF; Ghildyal N; McNeil HP; Austen KF; Gillis S; Stevens RL
    J Exp Med; 1992 Apr; 175(4):1003-12. PubMed ID: 1372640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions between mast cells, fibroblasts and connective tissue components.
    Atkins FM; Friedman MM; Subba Rao PV; Metcalfe DD
    Int Arch Allergy Appl Immunol; 1985; 77(1-2):96-102. PubMed ID: 3891632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of rat mast cell protease 1 activity. Protease inhibition is prevented by heparin proteoglycan.
    Pejler G; Berg L
    Eur J Biochem; 1995 Oct; 233(1):192-9. PubMed ID: 7588746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T11/CD2 activation of cloned human natural killer cells results in increased conjugate formation and exocytosis of cytolytic granules.
    Schmidt RE; Caulfield JP; Michon J; Hein A; Kamada MM; MacDermott RP; Stevens RL; Ritz J
    J Immunol; 1988 Feb; 140(3):991-1002. PubMed ID: 3276787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chymase bound to heparin is resistant to its natural inhibitors and capable of proteolyzing high density lipoproteins in aortic intimal fluid.
    Lindstedt L; Lee M; Kovanen PT
    Atherosclerosis; 2001 Mar; 155(1):87-97. PubMed ID: 11223430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucosal mast cells in the rat and in man.
    Enerbäck L
    Int Arch Allergy Appl Immunol; 1987; 82(3-4):249-55. PubMed ID: 2437041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation and characterization of a cDNA that encodes the peptide core of the secretory granule proteoglycan of human promyelocytic leukemia HL-60 cells.
    Stevens RL; Avraham S; Gartner MC; Bruns GA; Austen KF; Weis JH
    J Biol Chem; 1988 May; 263(15):7287-91. PubMed ID: 2835370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrastructural localization of heparin to human mast cells of the MCTC and MCT types by labeling with antithrombin III-gold.
    Craig SS; Irani AM; Metcalfe DD; Schwartz LB
    Lab Invest; 1993 Nov; 69(5):552-61. PubMed ID: 8246447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Degradation of the heparin matrix of mast cell granules by cultured fibroblasts.
    Atkins FM; Metcalfe DD
    J Immunol; 1983 Sep; 131(3):1420-5. PubMed ID: 6886421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.